Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Rapid correction of low vitamin D status in nursing home residents 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment
Top Ten Searches
rheumatoid arthritis lupus polymyalgia sjogrens fibromyalgia amyloidosis vasculitis urate raynauds myositisYour Article Summary
Nerve growth factor in rheumatic diseases
Seminars in Arthritis and Rheumatism, 06/30/09
Seidel MF et al. – Nerve growth factor (NGF), is a significant mediator and modulator of inflammation. NGF may shows detrimental or regenerative activity. These findings indicate potential therapeutic interventions using either NGF antagonists or recombinant NGF.
Methods- Review of the role of NGF in rheumatic diseases and strategies for potential therapeutic interventions
- Database search using Medline and Medpilot
- Assessment of 800 abstracts for keyword NGF and other keywords
- Analysis of articles based on relevance and content
- Inclusion of most clinical trials and studies with human specimens
- Selection of studies with experimental animal models with relevant data
- NGF overexpression in many inflammatory and degenerative rheumatic diseases
- Concentrations differ and may show contradictory results
- NGF in serum, synovial fluid, and cerebrospinal fluid, and tissue specimens
- NGF concentrations correlate with extent of inflammation and/or clinical activity in many conditions
- NGF levels significantly higher in rheumatoid arthritis vs osteoarthritis
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Hepatoprotective effect of TNF-alpha blockade in psoriatic arthritis: A cross-sectional study
Annals of Rheumatic Diseases, 11/09/09
Musculoskeletal manifestations in patients with malignant disease
Clinical Rheumatology, 11/13/09
The relationship between synovial lymphocyte aggregates and the clinical response to infliximab in rheumatoid arthritis: A prospective study
Arthritis & Rheumatism, 11/04/09
Sponsor
Article Search
Sponsor


See Latest Articles


